Global Drug Delivery Devices Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Drug Delivery Devices Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Drug Delivery Devices Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
  • 1.2.2 Injection Type
  • 1.2.3 Mucosal Type
  • 1.2.4 Implanted Type
  • 1.2.5 Others Type
• 1.3 Market by Application
  • 1.3.1 Global Drug Delivery Devices Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
  • 1.3.2 Pharmaceutical Companies
  • 1.3.3 Hospitals
  • 1.3.4 Clinics
  • 1.3.5 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Drug Delivery Devices Market Size Estimates and Forecasts
• 2.2 Drug Delivery Devices Market Size by Region: 2024 Versus 2031
  • 2.2.1 Global Drug Delivery Devices Revenue by Region: 2020-2025
  • 2.2.2 Global Drug Delivery Devices Revenue Forecast by Region (2026-2031)
  • 2.2.3 Global Drug Delivery Devices Revenue Market Share by Region (2020-2031)

3 Market Segments

• 3.1 Breakdown Data by Type
  • 3.1.1 Global Drug Delivery Devices Revenue by Type (2020-2031)
  • 3.1.2 Global Drug Delivery Devices Revenue Market Share by Type (2020-2031)
• 3.2 Breakdown Data by Application
  • 3.2.1 Global Drug Delivery Devices Revenue by Application (2020-2031)
  • 3.2.2 Global Drug Delivery Devices Revenue Market Share by Application (2020-2031)
• 3.3 by Type and by Application Crossing Analysis
  • 3.3.1 Injection Type of Drug Delivery Devices Revenue Market Share by Application
  • 3.3.2 Mucosal Type of Drug Delivery Devices Revenue Market Share by Application
  • 3.3.3 Implanted Type of Drug Delivery Devices Revenue Market Share by Application
  • 3.3.4 Others Type of Drug Delivery Devices Revenue Market Share by Application

4 Global Drug Delivery Devices by Company

• 4.1 Global Drug Delivery Devices Revenue by Company (2020-2025)
• 4.2 Global Drug Delivery Devices Revenue Share by Company (2020-2025)
• 4.3 Competitive Landscape
  • 4.3.1 Key Drug Delivery Devices Companies around the World: Ranking by Revenue
  • 4.3.2 Global Drug Delivery Devices Market Concentration Ratio (CR5 and HHI) & (2020-2025)
  • 4.3.3 Global Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.4 Global Drug Delivery Devices Companies Headquarters & Product Type
  • 4.4.1 Global Drug Delivery Devices Companies Headquarters
  • 4.4.2 Date of International Companies Enter into Drug Delivery Devices Market
  • 4.4.3 Global Drug Delivery Devices Companies Product & Service
  • 4.4.4 Injection Type Revenue Market Share of Drug Delivery Devices by Company
  • 4.4.5 Mucosal Type Revenue Market Share of Drug Delivery Devices by Company
  • 4.4.6 Implanted Type Revenue Market Share of Drug Delivery Devices by Company
  • 4.4.7 Others Type Revenue Market Share of Drug Delivery Devices by Company
• 4.5 Global Drug Delivery Devices Mergers & Acquisitions, Expansion Plans

5 Company Profiles

• 5.1 Cipla
  • 5.1.1 Cipla Corporation Information
  • 5.1.2 Cipla Description, Business Overview
  • 5.1.3 Cipla Drug Delivery Devices Products Offered
  • 5.1.4 Cipla Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.1.5 Cipla Drug Delivery Devices Revenue by Product in 2024
  • 5.1.6 Cipla Drug Delivery Devices Revenue by Application in 2024
  • 5.1.7 Cipla Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.1.8 Cipla Recent Developments
• 5.2 Baxter International
  • 5.2.1 Baxter International Corporation Information
  • 5.2.2 Baxter International Description, Business Overview
  • 5.2.3 Baxter International Drug Delivery Devices Products Offered
  • 5.2.4 Baxter International Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.2.5 Baxter International Drug Delivery Devices Revenue by Product in 2024
  • 5.2.6 Baxter International Drug Delivery Devices Revenue by Application in 2024
  • 5.2.7 Baxter International Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.2.8 Baxter International Recent Developments
• 5.3 Nipro Corporation
  • 5.3.1 Nipro Corporation Corporation Information
  • 5.3.2 Nipro Corporation Description, Business Overview
  • 5.3.3 Nipro Corporation Drug Delivery Devices Products Offered
  • 5.3.4 Nipro Corporation Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.3.5 Nipro Corporation Drug Delivery Devices Revenue by Product in 2024
  • 5.3.6 Nipro Corporation Drug Delivery Devices Revenue by Application in 2024
  • 5.3.7 Nipro Corporation Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.3.8 Nipro Corporation Recent Developments
• 5.4 Roche
  • 5.4.1 Roche Corporation Information
  • 5.4.2 Roche Description, Business Overview
  • 5.4.3 Roche Drug Delivery Devices Products Offered
  • 5.4.4 Roche Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.4.5 Roche Drug Delivery Devices Revenue by Product in 2024
  • 5.4.6 Roche Drug Delivery Devices Revenue by Application in 2024
  • 5.4.7 Roche Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.4.8 Roche Recent Developments
• 5.5 Boehringer Ingelheim
  • 5.5.1 Boehringer Ingelheim Corporation Information
  • 5.5.2 Boehringer Ingelheim Description, Business Overview
  • 5.5.3 Boehringer Ingelheim Drug Delivery Devices Products Offered
  • 5.5.4 Boehringer Ingelheim Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.5.5 Boehringer Ingelheim Drug Delivery Devices Revenue by Product in 2024
  • 5.5.6 Boehringer Ingelheim Drug Delivery Devices Revenue by Application in 2024
  • 5.5.7 Boehringer Ingelheim Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.5.8 Boehringer Ingelheim Recent Developments
• 5.6 Allergan
  • 5.6.1 Allergan Corporation Information
  • 5.6.2 Allergan Description, Business Overview
  • 5.6.3 Allergan Drug Delivery Devices Products Offered
  • 5.6.4 Allergan Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.6.5 Allergan Drug Delivery Devices Revenue by Product in 2024
  • 5.6.6 Allergan Drug Delivery Devices Revenue by Application in 2024
  • 5.6.7 Allergan Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.6.8 Allergan Recent Developments
• 5.7 3M
  • 5.7.1 3M Corporation Information
  • 5.7.2 3M Description, Business Overview
  • 5.7.3 3M Drug Delivery Devices Products Offered
  • 5.7.4 3M Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.7.5 3M Drug Delivery Devices Revenue by Product in 2024
  • 5.7.6 3M Drug Delivery Devices Revenue by Application in 2024
  • 5.7.7 3M Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.7.8 3M Recent Developments
• 5.8 BD
  • 5.8.1 BD Corporation Information
  • 5.8.2 BD Description, Business Overview
  • 5.8.3 BD Drug Delivery Devices Products Offered
  • 5.8.4 BD Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.8.5 BD Drug Delivery Devices Revenue by Product in 2024
  • 5.8.6 BD Drug Delivery Devices Revenue by Application in 2024
  • 5.8.7 BD Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.8.8 BD Recent Developments
• 5.9 Catalent
  • 5.9.1 Catalent Corporation Information
  • 5.9.2 Catalent Description, Business Overview
  • 5.9.3 Catalent Drug Delivery Devices Products Offered
  • 5.9.4 Catalent Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.9.5 Catalent Drug Delivery Devices Revenue by Product in 2024
  • 5.9.6 Catalent Drug Delivery Devices Revenue by Application in 2024
  • 5.9.7 Catalent Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.9.8 Catalent Recent Developments
• 5.10 Valeant Pharmaceuticals
  • 5.10.1 Valeant Pharmaceuticals Corporation Information
  • 5.10.2 Valeant Pharmaceuticals Description, Business Overview
  • 5.10.3 Valeant Pharmaceuticals Drug Delivery Devices Products Offered
  • 5.10.4 Valeant Pharmaceuticals Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.10.5 Valeant Pharmaceuticals Drug Delivery Devices Revenue by Product in 2024
  • 5.10.6 Valeant Pharmaceuticals Drug Delivery Devices Revenue by Application in 2024
  • 5.10.7 Valeant Pharmaceuticals Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.10.8 Valeant Pharmaceuticals Recent Developments
• 5.11 Bayer AG
  • 5.11.1 Bayer AG Corporation Information
  • 5.11.2 Bayer AG Description, Business Overview
  • 5.11.3 Bayer AG Drug Delivery Devices Products Offered
  • 5.11.4 Bayer AG Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.11.5 Bayer AG Drug Delivery Devices Revenue by Product in 2024
  • 5.11.6 Bayer AG Drug Delivery Devices Revenue by Application in 2024
  • 5.11.7 Bayer AG Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.11.8 Bayer AG Recent Developments
• 5.12 Chiesi
  • 5.12.1 Chiesi Corporation Information
  • 5.12.2 Chiesi Description, Business Overview
  • 5.12.3 Chiesi Drug Delivery Devices Products Offered
  • 5.12.4 Chiesi Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.12.5 Chiesi Drug Delivery Devices Revenue by Product in 2024
  • 5.12.6 Chiesi Drug Delivery Devices Revenue by Application in 2024
  • 5.12.7 Chiesi Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.12.8 Chiesi Recent Developments
• 5.13 Phillips-Medisize
  • 5.13.1 Phillips-Medisize Corporation Information
  • 5.13.2 Phillips-Medisize Description, Business Overview
  • 5.13.3 Phillips-Medisize Drug Delivery Devices Products Offered
  • 5.13.4 Phillips-Medisize Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.13.5 Phillips-Medisize Drug Delivery Devices Revenue by Product in 2024
  • 5.13.6 Phillips-Medisize Drug Delivery Devices Revenue by Application in 2024
  • 5.13.7 Phillips-Medisize Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.13.8 Phillips-Medisize Recent Developments
• 5.14 Johnson & Johnson
  • 5.14.1 Johnson & Johnson Corporation Information
  • 5.14.2 Johnson & Johnson Description, Business Overview
  • 5.14.3 Johnson & Johnson Drug Delivery Devices Products Offered
  • 5.14.4 Johnson & Johnson Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.14.5 Johnson & Johnson Drug Delivery Devices Revenue by Product in 2024
  • 5.14.6 Johnson & Johnson Drug Delivery Devices Revenue by Application in 2024
  • 5.14.7 Johnson & Johnson Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.14.8 Johnson & Johnson Recent Developments
• 5.15 Shandong Weigao
  • 5.15.1 Shandong Weigao Corporation Information
  • 5.15.2 Shandong Weigao Description, Business Overview
  • 5.15.3 Shandong Weigao Drug Delivery Devices Products Offered
  • 5.15.4 Shandong Weigao Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.15.5 Shandong Weigao Drug Delivery Devices Revenue by Product in 2024
  • 5.15.6 Shandong Weigao Drug Delivery Devices Revenue by Application in 2024
  • 5.15.7 Shandong Weigao Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.15.8 Shandong Weigao Recent Developments
• 5.16 Pfizer
  • 5.16.1 Pfizer Corporation Information
  • 5.16.2 Pfizer Description, Business Overview
  • 5.16.3 Pfizer Drug Delivery Devices Products Offered
  • 5.16.4 Pfizer Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.16.5 Pfizer Drug Delivery Devices Revenue by Product in 2024
  • 5.16.6 Pfizer Drug Delivery Devices Revenue by Application in 2024
  • 5.16.7 Pfizer Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.16.8 Pfizer Recent Developments
• 5.17 B.Braun
  • 5.17.1 B.Braun Corporation Information
  • 5.17.2 B.Braun Description, Business Overview
  • 5.17.3 B.Braun Drug Delivery Devices Products Offered
  • 5.17.4 B.Braun Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.17.5 B.Braun Drug Delivery Devices Revenue by Product in 2024
  • 5.17.6 B.Braun Drug Delivery Devices Revenue by Application in 2024
  • 5.17.7 B.Braun Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.17.8 B.Braun Recent Developments
• 5.18 Novartis AG
  • 5.18.1 Novartis AG Corporation Information
  • 5.18.2 Novartis AG Description, Business Overview
  • 5.18.3 Novartis AG Drug Delivery Devices Products Offered
  • 5.18.4 Novartis AG Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.18.5 Novartis AG Drug Delivery Devices Revenue by Product in 2024
  • 5.18.6 Novartis AG Drug Delivery Devices Revenue by Application in 2024
  • 5.18.7 Novartis AG Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.18.8 Novartis AG Recent Developments
• 5.19 Zhengkang
  • 5.19.1 Zhengkang Corporation Information
  • 5.19.2 Zhengkang Description, Business Overview
  • 5.19.3 Zhengkang Drug Delivery Devices Products Offered
  • 5.19.4 Zhengkang Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.19.5 Zhengkang Drug Delivery Devices Revenue by Product in 2024
  • 5.19.6 Zhengkang Drug Delivery Devices Revenue by Application in 2024
  • 5.19.7 Zhengkang Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.19.8 Zhengkang Recent Developments
• 5.20 Gerresheimer
  • 5.20.1 Gerresheimer Corporation Information
  • 5.20.2 Gerresheimer Description, Business Overview
  • 5.20.3 Gerresheimer Drug Delivery Devices Products Offered
  • 5.20.4 Gerresheimer Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.20.5 Gerresheimer Drug Delivery Devices Revenue by Product in 2024
  • 5.20.6 Gerresheimer Drug Delivery Devices Revenue by Application in 2024
  • 5.20.7 Gerresheimer Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.20.8 Gerresheimer Recent Developments
• 5.21 COVIDIEN Medtronic
  • 5.21.1 COVIDIEN Medtronic Corporation Information
  • 5.21.2 COVIDIEN Medtronic Description, Business Overview
  • 5.21.3 COVIDIEN Medtronic Drug Delivery Devices Products Offered
  • 5.21.4 COVIDIEN Medtronic Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.21.5 COVIDIEN Medtronic Drug Delivery Devices Revenue by Product in 2024
  • 5.21.6 COVIDIEN Medtronic Drug Delivery Devices Revenue by Application in 2024
  • 5.21.7 COVIDIEN Medtronic Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.21.8 COVIDIEN Medtronic Recent Developments
• 5.22 Schott forma vitrum
  • 5.22.1 Schott forma vitrum Corporation Information
  • 5.22.2 Schott forma vitrum Description, Business Overview
  • 5.22.3 Schott forma vitrum Drug Delivery Devices Products Offered
  • 5.22.4 Schott forma vitrum Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.22.5 Schott forma vitrum Drug Delivery Devices Revenue by Product in 2024
  • 5.22.6 Schott forma vitrum Drug Delivery Devices Revenue by Application in 2024
  • 5.22.7 Schott forma vitrum Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.22.8 Schott forma vitrum Recent Developments
• 5.23 Alkermes
  • 5.23.1 Alkermes Corporation Information
  • 5.23.2 Alkermes Description, Business Overview
  • 5.23.3 Alkermes Drug Delivery Devices Products Offered
  • 5.23.4 Alkermes Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.23.5 Alkermes Drug Delivery Devices Revenue by Product in 2024
  • 5.23.6 Alkermes Drug Delivery Devices Revenue by Application in 2024
  • 5.23.7 Alkermes Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.23.8 Alkermes Recent Developments
• 5.24 Skyepharma
  • 5.24.1 Skyepharma Corporation Information
  • 5.24.2 Skyepharma Description, Business Overview
  • 5.24.3 Skyepharma Drug Delivery Devices Products Offered
  • 5.24.4 Skyepharma Drug Delivery Devices Revenue and Gross Margin (2020-2025)
  • 5.24.5 Skyepharma Drug Delivery Devices Revenue by Product in 2024
  • 5.24.6 Skyepharma Drug Delivery Devices Revenue by Application in 2024
  • 5.24.7 Skyepharma Drug Delivery Devices Revenue by Geographic Area in 2024
  • 5.24.8 Skyepharma Recent Developments

6 North America

• 6.1 North America Drug Delivery Devices Market Size YoY Growth 2020-2031
• 6.2 North America Drug Delivery Devices Market Facts & Figures by Country (2020-2031)
• 6.3 North America Drug Delivery Devices Revenue by Type (2020-2025)
• 6.4 North America Drug Delivery Devices Revenue by Application (2020-2025)

7 Asia-Pacific

• 7.1 Asia-Pacific Drug Delivery Devices Market Size YoY Growth 2020-2031
• 7.2 Asia-Pacific Drug Delivery Devices Market Facts & Figures by Region (2020-2031)
• 7.3 Asia-Pacific Drug Delivery Devices Revenue by Type (2020-2025)
• 7.4 Asia-Pacific Drug Delivery Devices Revenue by Application (2020-2025)

8 Europe

• 8.1 Europe Drug Delivery Devices Market Size YoY Growth 2020-2031
• 8.2 Europe Drug Delivery Devices Market Facts & Figures by Country (2020-2031)
• 8.3 Europe Drug Delivery Devices Revenue by Type (2020-2025)
• 8.4 Europe Drug Delivery Devices Revenue by Application (2020-2025)

9 Latin America

• 9.1 Latin America Drug Delivery Devices Market Size YoY Growth 2020-2031
• 9.2 Latin America Drug Delivery Devices Market Facts & Figures by Country (2020-2031)
• 9.3 Latin America Drug Delivery Devices Revenue by Type (2020-2025)
• 9.4 Latin America Drug Delivery Devices Revenue by Application (2020-2025)

10 Middle East and Africa

• 10.1 Latin America Drug Delivery Devices Market Size YoY Growth 2020-2031
• 10.2 Middle East and Africa Drug Delivery Devices Market Facts & Figures by Country (2020-2031)
• 10.3 Middle East and Africa Drug Delivery Devices Revenue by Type (2020-2025)
• 10.4 Middle East and Africa Drug Delivery Devices Revenue by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

• 11.1 Drug Delivery Devices Supply Chain Analysis
• 11.2 Drug Delivery Devices Key Raw Materials and Upstream Suppliers
• 11.3 Drug Delivery Devices Clients Analysis
• 11.4 Drug Delivery Devices Sales Channel and Sales Model Analysis
  • 11.4.1 Drug Delivery Devices Distribution Channel Analysis: Indirect Sales VS Direct Sales
  • 11.4.2 Drug Delivery Devices Distribution Channel Analysis: Online Sales VS Offline Sales
  • 11.4.3 Drug Delivery Devices Distributors

12 Drug Delivery Devices Market Dynamics

• 12.1 Drug Delivery Devices Industry Trends
• 12.2 Drug Delivery Devices Market Drivers
• 12.3 Drug Delivery Devices Market Challenges
• 12.4 Drug Delivery Devices Market Restraints

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details
• 14.3 Disclaimer

List of Tables

Table 1. Global Drug Delivery Devices Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Drug Delivery Devices Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Drug Delivery Devices Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Drug Delivery Devices Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Drug Delivery Devices Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 6. Global Drug Delivery Devices Revenue by Type (2020-2025) & (US$ Million)

Table 7. Global Drug Delivery Devices Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 8. Global Drug Delivery Devices Revenue by Application (2020-2025) & (US$ Million)

Table 9. Global Drug Delivery Devices Revenue Forecast by Application (2026-2031) & (US$ Million)

Table 10. Drug Delivery Devices Revenue by Company (2020-2025) & (US$ Million)

Table 11. Drug Delivery Devices Revenue Share by Company (2020-2025)

Table 12. Ranking of Global Top Drug Delivery Devices Players by Revenue (US$ Million) in 2024

Table 13. Global Drug Delivery Devices Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 14. Global Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery Devices as of 2024)

Table 15. Global Drug Delivery Devices Companies Headquarters

Table 16. Date of International Companies Enter into Drug Delivery Devices Market

Table 17. Global Drug Delivery Devices Companies Product & Service

Table 18. Global Drug Delivery Devices Mergers & Acquisitions, Expansion Plans

Table 19. Cipla Corporation Information

Table 20. Cipla Description and Business Overview

Table 21. Cipla Drug Delivery Devices Product

Table 22. Cipla Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 23. Cipla Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 24. Cipla Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 25. Cipla Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 26. Cipla Recent Developments

Table 27. Baxter International Corporation Information

Table 28. Baxter International Description and Business Overview

Table 29. Baxter International Drug Delivery Devices Product

Table 30. Baxter International Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 31. Baxter International Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 32. Baxter International Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 33. Baxter International Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 34. Baxter International Recent Developments

Table 35. Nipro Corporation Corporation Information

Table 36. Nipro Corporation Description and Business Overview

Table 37. Nipro Corporation Drug Delivery Devices Product

Table 38. Nipro Corporation Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 39. Nipro Corporation Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 40. Nipro Corporation Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 41. Nipro Corporation Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 42. Nipro Corporation Recent Developments

Table 43. Roche Corporation Information

Table 44. Roche Description and Business Overview

Table 45. Roche Drug Delivery Devices Product

Table 46. Roche Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. Roche Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 48. Roche Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 49. Roche Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 50. Roche Recent Developments

Table 51. Boehringer Ingelheim Corporation Information

Table 52. Boehringer Ingelheim Description and Business Overview

Table 53. Boehringer Ingelheim Drug Delivery Devices Product

Table 54. Boehringer Ingelheim Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 55. Boehringer Ingelheim Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 56. Boehringer Ingelheim Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 57. Boehringer Ingelheim Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 58. Boehringer Ingelheim Recent Developments

Table 59. Allergan Corporation Information

Table 60. Allergan Description and Business Overview

Table 61. Allergan Drug Delivery Devices Product

Table 62. Allergan Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 63. Allergan Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 64. Allergan Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 65. Allergan Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 66. Allergan Recent Developments

Table 67. 3M Corporation Information

Table 68. 3M Description and Business Overview

Table 69. 3M Drug Delivery Devices Product

Table 70. 3M Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 71. 3M Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 72. 3M Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 73. 3M Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 74. 3M Recent Developments

Table 75. BD Corporation Information

Table 76. BD Description and Business Overview

Table 77. BD Drug Delivery Devices Product

Table 78. BD Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 79. BD Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 80. BD Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 81. BD Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 82. BD Recent Developments

Table 83. Catalent Corporation Information

Table 84. Catalent Description and Business Overview

Table 85. Catalent Drug Delivery Devices Product

Table 86. Catalent Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 87. Catalent Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 88. Catalent Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 89. Catalent Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 90. Catalent Recent Developments

Table 91. Valeant Pharmaceuticals Corporation Information

Table 92. Valeant Pharmaceuticals Description and Business Overview

Table 93. Valeant Pharmaceuticals Drug Delivery Devices Product

Table 94. Valeant Pharmaceuticals Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 95. Valeant Pharmaceuticals Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 96. Valeant Pharmaceuticals Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 97. Valeant Pharmaceuticals Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 98. Valeant Pharmaceuticals Recent Developments

Table 99. Bayer AG Corporation Information

Table 100. Bayer AG Description and Business Overview

Table 101. Bayer AG Drug Delivery Devices Product

Table 102. Bayer AG Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. Bayer AG Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 104. Bayer AG Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 105. Bayer AG Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 106. Bayer AG Recent Developments

Table 107. Chiesi Corporation Information

Table 108. Chiesi Description and Business Overview

Table 109. Chiesi Drug Delivery Devices Product

Table 110. Chiesi Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 111. Chiesi Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 112. Chiesi Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 113. Chiesi Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 114. Chiesi Recent Developments

Table 115. Phillips-Medisize Corporation Information

Table 116. Phillips-Medisize Description and Business Overview

Table 117. Phillips-Medisize Drug Delivery Devices Product

Table 118. Phillips-Medisize Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 119. Phillips-Medisize Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 120. Phillips-Medisize Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 121. Phillips-Medisize Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 122. Phillips-Medisize Recent Developments

Table 123. Johnson & Johnson Corporation Information

Table 124. Johnson & Johnson Description and Business Overview

Table 125. Johnson & Johnson Drug Delivery Devices Product

Table 126. Johnson & Johnson Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 127. Johnson & Johnson Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 128. Johnson & Johnson Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 129. Johnson & Johnson Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 130. Johnson & Johnson Recent Developments

Table 131. Shandong Weigao Corporation Information

Table 132. Shandong Weigao Description and Business Overview

Table 133. Shandong Weigao Drug Delivery Devices Product

Table 134. Shandong Weigao Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 135. Shandong Weigao Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 136. Shandong Weigao Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 137. Shandong Weigao Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 138. Shandong Weigao Recent Developments

Table 139. Pfizer Corporation Information

Table 140. Pfizer Description and Business Overview

Table 141. Pfizer Drug Delivery Devices Product

Table 142. Pfizer Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 143. Pfizer Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 144. Pfizer Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 145. Pfizer Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 146. Pfizer Recent Developments

Table 147. B.Braun Corporation Information

Table 148. B.Braun Description and Business Overview

Table 149. B.Braun Drug Delivery Devices Product

Table 150. B.Braun Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 151. B.Braun Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 152. B.Braun Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 153. B.Braun Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 154. B.Braun Recent Developments

Table 155. Novartis AG Corporation Information

Table 156. Novartis AG Description and Business Overview

Table 157. Novartis AG Drug Delivery Devices Product

Table 158. Novartis AG Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 159. Novartis AG Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 160. Novartis AG Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 161. Novartis AG Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 162. Novartis AG Recent Developments

Table 163. Zhengkang Corporation Information

Table 164. Zhengkang Description and Business Overview

Table 165. Zhengkang Drug Delivery Devices Product

Table 166. Zhengkang Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 167. Zhengkang Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 168. Zhengkang Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 169. Zhengkang Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 170. Zhengkang Recent Developments

Table 171. Gerresheimer Corporation Information

Table 172. Gerresheimer Description and Business Overview

Table 173. Gerresheimer Drug Delivery Devices Product

Table 174. Gerresheimer Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 175. Gerresheimer Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 176. Gerresheimer Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 177. Gerresheimer Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 178. Gerresheimer Recent Developments

Table 179. COVIDIEN Medtronic Corporation Information

Table 180. COVIDIEN Medtronic Description and Business Overview

Table 181. COVIDIEN Medtronic Drug Delivery Devices Product

Table 182. COVIDIEN Medtronic Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 183. COVIDIEN Medtronic Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 184. COVIDIEN Medtronic Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 185. COVIDIEN Medtronic Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 186. COVIDIEN Medtronic Recent Developments

Table 187. Schott forma vitrum Corporation Information

Table 188. Schott forma vitrum Description and Business Overview

Table 189. Schott forma vitrum Drug Delivery Devices Product

Table 190. Schott forma vitrum Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 191. Schott forma vitrum Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 192. Schott forma vitrum Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 193. Schott forma vitrum Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 194. Schott forma vitrum Recent Developments

Table 195. Alkermes Corporation Information

Table 196. Alkermes Description and Business Overview

Table 197. Alkermes Drug Delivery Devices Product

Table 198. Alkermes Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 199. Alkermes Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 200. Alkermes Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 201. Alkermes Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 202. Alkermes Recent Developments

Table 203. Skyepharma Corporation Information

Table 204. Skyepharma Description and Business Overview

Table 205. Skyepharma Drug Delivery Devices Product

Table 206. Skyepharma Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2020-2025)

Table 207. Skyepharma Revenue Proportion of Drug Delivery Devices by Product in 2024

Table 208. Skyepharma Revenue Proportion of Drug Delivery Devices by Application in 2024

Table 209. Skyepharma Revenue Proportion of Drug Delivery Devices by Geographic Area in 2024

Table 210. Skyepharma Recent Developments

Table 211. North America Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)

Table 212. North America Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)

Table 213. North America Drug Delivery Devices Revenue by Type (2020-2025) & (US$ Million)

Table 214. North America Drug Delivery Devices Revenue by Application (2020-2025) & (US$ Million)

Table 215. Asia-Pacific Drug Delivery Devices Revenue by Region (2020-2025) & (US$ Million)

Table 216. Asia-Pacific Drug Delivery Devices Revenue by Region (2026-2031) & (US$ Million)

Table 217. Asia-Pacific Drug Delivery Devices Revenue by Type (2020-2025) & (US$ Million)

Table 218. Asia-Pacific Drug Delivery Devices Revenue by Application (2020-2025) & (US$ Million)

Table 219. Europe Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)

Table 220. Europe Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)

Table 221. Europe Drug Delivery Devices Revenue by Type (2020-2025) & (US$ Million)

Table 222. Europe Drug Delivery Devices Revenue by Application (2020-2025) & (US$ Million)

Table 223. Latin America Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)

Table 224. Latin America Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)

Table 225. Latin America Drug Delivery Devices Revenue by Type (2020-2025) & (US$ Million)

Table 226. Latin America Drug Delivery Devices Revenue by Application (2020-2025) & (US$ Million)

Table 227. Middle East and Africa Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)

Table 228. Middle East and Africa Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)

Table 229. Middle East and Africa Drug Delivery Devices Revenue by Type (2020-2025) & (US$ Million)

Table 230. Middle East and Africa Drug Delivery Devices Revenue by Application (2020-2025) & (US$ Million)

Table 231. Drug Delivery Devices Key Raw Materials, Industry Status and Trend

Table 232. Drug Delivery Devices Key Raw Materials and Upstream Suppliers

Table 233. Drug Delivery Devices Clients Status and Trend

Table 234. Drug Delivery Devices Typical Clients

Table 235. Drug Delivery Devices Distributors

Table 236. Drug Delivery Devices Market Trends

Table 237. Drug Delivery Devices Market Drivers

Table 238. Drug Delivery Devices Market Challenges

Table 239. Drug Delivery Devices Market Restraints

Table 240. Research Programs/Design for This Report

Table 241. Key Data Information from Secondary Sources

Table 242. Key Data Information from Primary Sources

List of Figures

Figure 1. Drug Delivery Devices Product Picture

Figure 2. Global Drug Delivery Devices Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Drug Delivery Devices Revenue Market Share by Type in 2024 & 2031

Figure 4. Injection Type Product Picture

Figure 5. Mucosal Type Product Picture

Figure 6. Implanted Type Product Picture

Figure 7. Others Type Product Picture

Figure 8. Global Drug Delivery Devices Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 9. Global Drug Delivery Devices Revenue Market Share by Application in 2024 & 2031

Figure 10. Pharmaceutical Companies

Figure 11. Hospitals

Figure 12. Clinics

Figure 13. Other

Figure 14. Drug Delivery Devices Report Years Considered

Figure 15. Global Drug Delivery Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Drug Delivery Devices Market Size (2020-2031) & (US$ Million)

Figure 17. Global Drug Delivery Devices Market Size Market Share by Region: 2024 Versus 2031

Figure 18. Global Drug Delivery Devices Revenue Market Share by Region (2020-2031)

Figure 19. Global Drug Delivery Devices Revenue Market Share Forecast by Type (2020-2031)

Figure 20. Global Drug Delivery Devices Revenue Market Share Forecast by Application (2020-2031)

Figure 21. Injection Type of Drug Delivery Devices Revenue Market Share by Application, 2024 VS 2031

Figure 22. Mucosal Type of Drug Delivery Devices Revenue Market Share by Application, 2024 VS 2031

Figure 23. Implanted Type of Drug Delivery Devices Revenue Market Share by Application, 2024 VS 2031

Figure 24. Others Type of Drug Delivery Devices Revenue Market Share by Application, 2024 VS 2031

Figure 25. Drug Delivery Devices Revenue Share by Company (2024)

Figure 26. Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 27. Injection Type Revenue Proportion by Company in 2024

Figure 28. Mucosal Type Revenue Proportion by Company in 2024

Figure 29. Implanted Type Revenue Proportion by Company in 2024

Figure 30. Others Type Revenue Proportion by Company in 2024

Figure 31. North America Drug Delivery Devices Revenue 2020-2031 (US$ Million)

Figure 32. North America Drug Delivery Devices Revenue Market Share by Type (2020-2025)

Figure 33. North America Drug Delivery Devices Revenue Market Share by Application (2020-2025)

Figure 34. Asia-Pacific Drug Delivery Devices Revenue 2020-2031 (US$ Million)

Figure 35. Asia-Pacific Drug Delivery Devices Revenue Market Share by Region (2020-2031)

Figure 36. Asia-Pacific Drug Delivery Devices Revenue Market Share by Type (2020-2025)

Figure 37. Asia-Pacific Drug Delivery Devices Revenue Market Share by Application (2020-2025)

Figure 38. Europe Drug Delivery Devices Revenue Growth Rate 2020-2031 (US$ Million)

Figure 39. Europe Drug Delivery Devices Revenue Market Share by Country (2020-2031)

Figure 40. Europe Drug Delivery Devices Revenue Market Share by Type (2020-2025)

Figure 41. Europe Drug Delivery Devices Revenue Market Share by Application (2020-2025)

Figure 42. Latin America Drug Delivery Devices Revenue Growth Rate 2020-2031 (US$ Million)

Figure 43. Latin America Drug Delivery Devices Revenue Market Share by Country (2020-2031)

Figure 44. Latin America Drug Delivery Devices Revenue Market Share by Type (2020-2025)

Figure 45. Latin America Drug Delivery Devices Revenue Market Share by Application (2020-2025)

Figure 46. Middle East and Africa Drug Delivery Devices Revenue Growth Rate 2020-2031 (US$ Million)

Figure 47. Middle East and Africa Drug Delivery Devices Revenue Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Drug Delivery Devices Revenue Market Share by Type (2020-2025)

Figure 49. Middle East and Africa Drug Delivery Devices Revenue Market Share by Application (2020-2025)

Figure 50. Drug Delivery Devices Supply Chain (Upstream and Downstream Market)

Figure 51. Global Production Market Share of Drug Delivery Devices Raw Materials by Region in 2024

Figure 52. Drug Delivery Devices Distribution Channels

Figure 53. Global Drug Delivery Devices Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 54. Global Drug Delivery Devices Percentage 2020-2031: Online Sales VS Offline Sales

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed